Alexander, E. K., et al. (2017). "2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum." Thyroid 27(3): 315-389. Azizi, F. and A. Amouzegar (2011). "Management of hyperthyroidism during pregnancy and lactation." European Journal of Endocrinology, Supplement 164(6): 871-876. Azizi, F., et al. (2016). "Prevalent practices of thyroid diseases during pregnancy among endocrinologists, internists and general practitioners." International Journal of Endocrinology and Metabolism 14(1). Bernard, D., et al. (2013). "Radioiodine 131 therapy in hyperthyroidism Evaluation of French nuclear medicine practice." European Journal of Nuclear Medicine and Molecular Imaging 40: S233. Chakrabarti, B. (2001). "Radio-iodine (NaI131) therapy in hyperthyroidism." Journal of the Indian Medical Association 99(11): 642-645. Claret-Torrents, C., et al. (2009). "Hyperthyroidism in Down síndrome." SD Revista Medica Internacional sobre el Sindrome de Down 13(1): 2-8. De Luca, F., et al. (2016). "Management of hyperthyroidism in children." Expert Review of Endocrinology and Metabolism 11(4): 301-309. Fatourechi, M. M. and V. Fatourechi (2014). "An update on subclinical hypothyroidism and subclinical hyperthyroidism." Expert Review of Endocrinology and Metabolism 9(2): 137-151. Korsch, E. (2010). "Impact of maternal thyreoidal antibodies on the neonatal thyroid function." Hormone Research in Paediatrics 74: 254. Menendez, S. G. and S. Casula (2015). "'Toxic multinodular goiter in patient biochemically euthyroid." Endocrine Reviews 36. Rojas, C. R., et al. (2016). "A case of recurrent metastatic struma ovarii." Endocrine Reviews 37(2). Tamhane, S. and H. Gharib (2016). ""Thyroid nodule update on diagnosis and management." Clinical Diabetes and Endocrinology 2(1). Vanes, N. K., et al. (2011). "Thyroid function in pregnancy: Maternal and fetal outcomes with hypothyroidism and subclinical thyroid dysfunction." Fetal and Maternal Medicine Review 22(3): 169-187. Villagelin, D., et al. (2014). "The prolonged use of low doses of methimazole is an interesting therapeutic alternative for relapsed graves' disease patients." Endocrine Reviews 35. Villagelin, D., et al. (2014). "The prolonged use of low doses of methimazole is an interesting therapeutic alternative for relapsed graves' disease patients." Endocrine Reviews 35. Weetman, A. (2016). "Recommended management of thyroid disorders." Prescriber 27(12): 31-38. Wright, H. V. and D. J. Williams (2013). ""Thyrotoxicosis in pregnancy." Fetal and Maternal Medicine Review 24(2): 108-128. Wysocki, J., et al. (2010). ""Thyrotoxicosis induced cholestasis." American Journal of Gastroenterology 105: S268. Døssing, H., et al. (2007). "Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules." European Journal of Endocrinology, Supplement 157(1): 95-100. Havrdova, E., et al. (2015). "Alemtuzumab in the treatment of multiple sclerosis: Key clinical trial results and considerations for use." Therapeutic Advances in Neurological Disorders 8(1): 31-45. Kyrilli, A., et al. (2015). Thiamazole pretreatment lowers the 131I activity needed to cure hyperthyroidism in patients with nodular goiter. 100: 2261-2267. Mellington, F. E., et al. (2017). "Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit." Orbit 36(3): 159-169. Ross, D. S. (2011). "The author replies." New England Journal of Medicine 364(20): 1978- 1979. Sherman, S. I., et al. (2015). "Relationship between thyroid-stimulating hormone levels and outcomes from the randomized, double-blind, phase 3 study of (e7080) lenvatinib in differentiated cancer of the thyroid (SELECT)." Endocrine Reviews 36. Wai, D. (2011). "Updates on the medical treatment for thyroid disease." Annals of the Academy of Medicine Singapore 40(7): S14. (2014). "Abstracts of the 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine, ANZSNM 2014." Internal Medicine Journal 44. Abraham, P. and S. Acharya (2010). "Current and emerging treatment options for graves' hyperthyroidism." Therapeutics and Clinical Risk Management 6(1): 29-40. Ahmed, T. (2013). "The state of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease." Journal of Labelled Compounds and Radiopharmaceuticals 56: $278. Akturk, H. K., et al. (2016). "Thyrotoxicosis with non-suppressed TSH: Diagnostic and therapeutic trial of short acting octreotide in a patient with non-localizable TSH- secreting tumor." Endocrine Reviews 37(2). Albu, S. E., et al. (2016). "Thyroid autoimmune disease: Between hypothyroidism and hyperthyroidism." Archives of the Balkan Medical Union 51(4): 483-487. Alkaabi, F., et al. (2015). "Association between hyperthyroidism and pulmonary hypertension." Endocrine Reviews 36. Alwagdani, A. and J. L. Cohen (2015). "Recurrent episodes of silent thyroiditis presenting as atrial tachyarrythmias." Endocrine Reviews 36. Amer, H., et al. (2015). "Isolated acropachy preceding hyperthyroidism: A case report." Thyroid 25: A322. Anaedo, H., et al. (2015). "The prevalence of incidental papillary thyroid cancer in patients undergoing thyroid surgery for presumed benign disease." Thyroid 25: A93. Anaedo, H. I., et al. (2015). "Primary ovarian failure, a rare occurence in intermediate CGG repeat fragile X carrier: A case report." Endocrine Reviews 36. Azem, F. and G. Shefer (2016). "High dose radioiodine therapy affects ovarian reserve." Fertility and Sterility 106: e131. Azizi, F., et al. (2011). "Long-term continuous methimazole or radioiodine treatment for hyperthyroidism." Endocrine Reviews 32(3). Azorín Belda, M. J., et al. (2017). "Recombinant human thyrotropin stimulation prior to 131I therapy in toxic multinodular goitre with low radioactive iodine uptake." Revista Espanola de Medicina Nuclear e Imagen Molecular 36(1): 7-12. Baiocco, C., et al. (2013). "Twelve months follow up after 131Iodine treatment in 342 patients with different types of hyperthyroidism." Clinical and Translational Imaging 1: S121. Balaguruswamy, S. and S. Jones (2009). "Audit on the management of thyrotoxicosis in the clinic at a District General Hospital." Endocrine Abstracts 19: P385. Ballal, S., et al. (2017). "Re-establishment of normal radioactive iodine uptake reference range in the era of universal salt iodization in the Indian population." Indian Journal of Medical Research 145(March): 358-364. Bellabarba, D. and N. Van Rossum (2014). "Recurrent hyper-and hypothyroidism over a period of 5 years." Thyroid 24: A9. Bernet, V. and A. M. Chindris (2012). "The potential dangers of supplements and herbal products marketed for improved thyroid function." Expert Review of Endocrinology and Metabolism 7(3): 247-249. Biswas, D., et al. (2015). "Occurrence of osteoporosis & factors determining bone mineral loss in young adults with graves' disease." Indian Journal of Medical Research, Supplement 141(Mar2015): 322-329. Boj Carceller, D., et al. (2014). "Clinical results and benefits of treatment with a 131I fixed dose compared with no treatment in patients with subclinical hiperthyroidism: Prospective cohort study." European Journal of Nuclear Medicine and Molecular Imaging 41: S541. Bontha, S., et al. (2001). "Use of volume derived from three-dimensional computed tomography to follow-up a retrosternal compressive toxic multinodular goiter treated with 131I." Endocrinologist 11(3): 247-249. Bothra, N., et al. (2017). "Hashimoto's thyroiditis: relative recurrence risk ratio and implications for screening of f rst-degree relatives." Clinical Endocrinology 87(2): 201- 206. Brona, A., et al. (2010). "Predictors of cardiovascular risk in patients with hyperthyroidism before and after radioiodine therapy." Endocrine Abstracts 22: P802. Brown, K. R., et al. (2013). "Resolution of chronic urticaria in two pediatric patients following treatment of graves' disease." Annals of Allergy, Asthma and Immunology 111(5): A59. Caetano, L. A., et al. (2011). "Thyroid hormone resistance and pituitary incidentaloma." Endocrine Reviews 32(3). Campenni, A., et al. (2013). "Iodine-131 treatment of hyperthyroidism: A retrospective study." Clinical and Translational Imaging 1: S120. Campenni, A., et al. (2017). "Iodine-131 treatment of hyperthyroidism: A retrospective study." Clinical and Translational Imaging 5: S61. Canali, E., et al. (2017). "Hyperthyroidism treatment with a custome dose vs standard therapy." Clinical and Translational Imaging 5: S61. Cardoso, R., et al. (2015). "Newborns of mothers with graves' disease: Survey of 14 years." Hormone Research in Paediatrics 84: 561. Carluccio, A. L., et al. (2012). "Apatjetoc thyrotoxicosis secondary to atypical subacute thyroiditis." Endocrine Practice 18(5): e127-e129. Chakrabarti, S. (2015). "Normokalemic thyrotoxic periodic paralysis with preserved reflexes- A unique case report." Journal of Clinical and Diagnostic Research 9(2): OD05- OD06. a. Chandrasekera, H., et al. (2013). "A resistant case of thyrotoxicosis in a patient with graves' disease." Endocrine Reviews 34(3). Chang, T. C. (2007). "Clinical application of thyroid and parathyroid ultrasonography in the outpatient clinic." Journal of Medical Ultrasound 15(3): 135-140. Chang, Z. (2017). "Mmind the gap: Flimsy follow-up leads to toxic thyroid." Journal of General Internal Medicine 32(2): S541-S542. Chillarón Jordán, J. J., et al. (2005). "Thyroid disorders in Down's syndrome." SD Revista Medica Internacional sobre el Sindrome de Down 9(3): 34-39. Clark, C. and C. Knight (2016). "Relapsing thyrotoxicosis after total thyroidectomy in a patient with graves' disease." Journal of General Internal Medicine 31(2): S717-S718. Cohn, A., et al. (2017). "Radioactive iodine treatment for hyperthyroidism in a patient with end stage renal disease." Endocrine Reviews 38(3). Cullen, E. M. and K. B. Gebke (2013). "Palpitations in a softball player." Clinical Journal of Sport Medicine 23(2): e14. Cunha, F. M., et al. (2014). "Methimazole-induced agranulocytosis in a patient with graves disease." European Thyroid Journal 3: 207-208. Dardi, I. K., et al. (2015). "A case of hypothyroidism in a cat owner with methimazole use for the treatment of feline hyperthyroidism." Thyroid 25: A66. Davidenko, I., et al. (2012). "Unmarked case of amiodarone-induced thyrotoxicosis." European Thyroid Journal 1: 133. Del Mundo, K., et al. (2013). "Outcome of radioiodine therapy in benign nodular nontoxic goite." European Journal of Nuclear Medicine and Molecular Imaging 40: S353. Dela Cruz, K., et al. (2013). "Outcome of radioiodine therapy in benign nodular non-toxic goiter." Journal of Labelled Compounds and Radiopharmaceuticals 56: S280. Demirel, K., et al. (2011). "Outcome of radioiodine therapy in patients with hyperthyroidism: Calculated doses vs. Fixed doses." European Journal of Nuclear Medicine and Molecular Imaging 38: S431-S432. Dhingra, V. K. and N. Bhatia (2015). "Use of telemedicine for facilitation of follow-up of patients of hyperthyroidism after definitive therapy with radioiodine in a primarily hilly state." Indian Journal of Nuclear Medicine 30(5): S27. Dodig, D., et al. (2003). "Treatment of Graves' disease with radioiodine (I131)." Paediatria Croatica, Supplement 47(1): 113-116. Ecker, J. L. and T. J. Musci (2000). "Thyroid function and disease in pregnancy." Current Problems in Obstetrics, Gynecology and Fertility 23(3): 109-122. El Bez, I., et al. (2014). "Iodine-131 treatment of hyperthyroidism in people older than 65 years." European Journal of Nuclear Medicine and Molecular Imaging 41: S547. Eugenio, F., et al. (2016). "Retrospective analysis of thyroid function tests in patients with grave's disease treated with protocol-based dosing of methimazole in a safety-net endocrinology clinic." Endocrine Reviews 37(2). Frossard, M. M., et al. (2017). "Unreliability of the tsh upper-reference limit alone and the importance of thyroid autoantibodies to predict subclinical hypothyroidism in turner syndrome." Endocrine Reviews 38(3). Ganjoo, N. and V. Puthi (2016). "Primary cutaneous amyloidosis in an adolescent with graves' disease: Previously unknown association." Archives of Disease in Childhood 101: A278-A279. García-Agulló, D. O., et al. (2006). "Radioiodine in hyperthyroidism: Long-term outcomes." Endocrinologia y Nutricion 53(7): 435-439. Gavrila, A., et al. (2014). "Variable brown adipose tissue response to the thyroid hormone status." Thyroid 24: A113-A114. Genovesi, M., et al. (2011). "Thyroid diseases in the Casentino area." Italian Journal of Medicine 5(2): 45. Gessl, A., et al. (2012). Thyroid disorders. 214: 361-386. Gibb, F. W., et al. (2012). "Risk factors for treatment failure, indicators of incipient hypothyroidism and assessment of weight gain following radioiodine therapy for graves thyrotoxicosis." Endocrine Reviews 33(3). Gibson, S. M. and A. Abou-Samra (2012). "Pseudotumor cerebri in a patient with graves disease, is there an association?" Endocrine Reviews 33(3). Gietka-Czernel, M. (2017). "The thyroid gland in postmenopausal women: Physiology and diseases." Przeglad Menopauzalny 16(2): 33-37. Gray, M., et al. (2011). "Radionuclide dosimetry in thyrotoxicosis - A 10 year patient study." European Journal of Nuclear Medicine and Molecular Imaging 38: S238. Greeve, J. (2003). "Thyroid disorders during pregnancy." Gynakologe 36(11): 965-973. Gu, Y., et al. (2016). "Pulmonary hypertension aggravated by hyperthyroidism: A case report." Endocrine Reviews 37(2). Hamidi, O., et al. (2016). "Outcomes of patients with benign thyroid nodules treated with radiofrequency ablation: A retrospective single-center case series." Thyroid 26: A43. Heringer, L. and H. Crevensten (2010). "Recurrent paralysis due to hyperthyroidism causing hypokalemia." Journal of General Internal Medicine 25: S544-S545. Hoff, A. O., et al. (2014). "Reversal of T3 thyrotoxicosis by lenvatinib in metastatic follicular thyroid carcinoma: Report of 2 cases." Endocrine Reviews 35. Hookham, J., et al. (2017). "Variation in the use of definitive treatment options in the management of graves' disease: A UK clinician survey." Postgraduate Medical Journal 93(1098): 198-204. Hou, H., et al. (2016). "Fixed dose of radioiodine (5 mCi) for the treatment of Graves' disease: Is it possible to predict outcome before therapy?" Molecular Imaging and Biology 18(1): S971. Hou, S. S., et al. (2010). "Analysis of influencing factors for therapeutic effects of 131I therapy for hyperthyroidism." Journal of Shanghai Jiaotong University (Medical Science) 30(9): 1055-1058. Isik, S., et al. (2011). "Relationship between thyroid nodules and adrenal incidentalomas." Endocrine Reviews 32(3). Izkhakov, E., et al. (2016). "Drug versus radioactive treatment of graves' disease- metabolic outcomes." Endocrine Reviews 37(2). Jiang, N., et al. (2015). "Follow-up and evaluation of the pregnancy outcome in women at reproductive age with graves'hyperthyroidism after 131-iodine treatment." Thyroid 25: A79. Jiménez, C. M., et al. (2014). "Results of radioiodine treatment in patients with goiter multinodular and toxic adenoma." European Thyroid Journal 3: 178. Johnstone, H. C., et al. (2004). "The evaluation and management of thyrotoxicosis." Current Paediatrics 14(5): 430-437. Jukić, T., et al. (2011). "Thyroid dysfunction and treatment strategy in patients on amiodarone therapy." European Thyroid Journal: 175-176. JuMc, T., et al. (2011). "Amiodarone induced thyroid dysfunction." Nuklearmedizin 50(2): A148. Jung, I. A., et al. (2015). "Nonautoimmune neonatal hyperthyroidism due to A633G mutation in the thyrotropin receptor gene." Hormone Research in Paediatrics 84: 306. Kamoun, T., et al. (2013). "Factors influencing the success of Radio-iodine dose in the treatment of Graves disease: One year outcom." European Journal of Nuclear Medicine and Molecular Imaging 40: S232. Khan, S. H., et al. (2017). "Radioactive iodine-131 as a definitive treatment in rare association of down syndrome with hyperthyroidism: A case report and review of literature." Indian Journal of Nuclear Medicine 32(1): 19-24. Kijek, J., et al. (2010). "The outcome of radioiodine therapy in Graves' hyperthyroidism: Thyroid size as prognostic factor." Endocrine Abstracts 20: P123. Kijek, J., et al. (2010). "The TSH receptor antibody levels (TSHRAb) and thyroid function after 131I therapy in patients with Graves' disease - 10 years follow-up." Endocrine Abstracts 20: P122. Kijek, J., et al. (2010). "TSH receptor antibody levels (TSHAb) in hyperthyroid patients with Graves' disease (GD): An evaluation of the outcome of 131I therapy." Endocrine Abstracts 22: P830. Kim, D., et al. (2013). "Thyrotoxicosis and abdominal symptoms-a diagnostic challenge." Journal of General Internal Medicine 28: S407. Kim, P. J., et al. (2012). "The effect of thyroid scintigraphy on thyroid function test among the patients with subclinical hyperthyroidism." Endocrine Reviews 33(3). Kim, Y. A., et al. (2016). "Long-term clinical course after antithyroid drug treatment in patients with graves' disease." Endocrine Reviews 37(2). Kobayashi, S., et al. (2015). "Effectiveness of levothyroxine therapy targeting a thyrotropin level lower than 2.5 mu/ l during the first trimester in preventing miscarriage: A prospective study at a single institution." Thyroid 25: A188. Korula, S., et al. (2015). "Graves' disease in children less than 8 years of age: Review of features and treatment outcome." International Journal clinical of   Pediatric Endocrinology 2015. Kung, F. P., et al. (2012). "Graves' ophthalmopathy." Journal of Internal Medicine of Taiwan 23(1): 9-20. Kwok, C., et al. (2004). "Standard-dose prescription of radioiodine therapy for thyrotoxicosis: The Queen Mary Hospital experience." Journal of the Hong Kong College of Radiologists 7(4): 187-194. Kyrilli, A., et al. (2013). "Thiamazol increases iodine uptake and allows a reduction of radioiodine dose needed to treat subclinical hyperthyroidism in patients with multinodular goiter." European Thyroid Journal 2: 145. Lai, J. and V. Wong (2017). "Urinary iodine as a predictor of lag-time to hypothyroidism in patients treated with iodine-131 for grave's disease." Clinical Endocrinology 86: 35-36. Larrad Jiménez, A. and A. Sitges Serra (2005). "Advances in surgical treatment." Endocrinologia y Nutricion 52(SUPPL. 1): 11-17. Laurberg, P., et al. (2013). "Prediction of remission during antithyroid drug therapy of graves' disease." Thyroid 23: A19. Lee, Y., et al. (2013). "Comparison between total thyroidectomy and subtotal thyroidectomy in graves' disease." Thyroid 23: A83-A84. Leighton, K. and N. Priddee (2017). "The disappearing haemoglobinopathy trait." British Journal of Haematology 176: 102. Leung, B. C. H. (2003). "Management of thyroid nodules." Hong Kong Practitioner 25(12): 611-615. Levy, M. (2008). "Assessment and management of thyroid disease." Foundation Years 4(6): 237-240. Liu, X., et al. (2014). "Antithyroid drug therapy holds good for recurrent graves' disease." Endocrine Reviews 35. Mahapatra, A. and M. Sood (2015). "Hyperthyroidism on long-term lithium carbonate therapy: A case report." Indian Journal of Psychiatry 57(5): S142-S143. Mahmood, M. and T. Ulahannan (2009). "Recurrence of hyperthyroidism - 12 years after radioiodine induced hypothyroidism; A case report." Endocrine Abstracts 19: P104. McCormack, A. I. and D. L. Learoyd (2006). "A guide to thyroid dysfunction." Medicine Today 7(5): 28-35. Michelon, F., et al. (2013). "A case of medical malpractice in differentiated thyroid carcinoma (DTC): A case report." Clinical and Translational Imaging 1: S45. Micle, I., et al. (2010). "Diagnostic and treatment difficulties in an infant born to a mother with Graves' disease." Hormone Research in Paediatrics 74: 289. Miller, T., et al. (2013). "Detection, incidence, and management of thyroid autoimmunity in comparison of alemtuzumab and rebif® in multiple sclerosis (CARE-MS) I and II." Neurology 80(1). Mitra, S., et al. (2010). "Does thyroxine suppression therapy help to rationalize surgery in benign euthyroid nodules." Indian Journal of Nuclear Medicine 25(2): 57-61. Mojsak, M. N., et al. (2012). "The influence of single low dose (0,03 mg) recombinant human thyrotropin (rhTSH) on I-131 uptake and function of large multinodular goitre." European Journal of Nuclear Medicine and Molecular Imaging 39: S339. Mori, M., et al. (2016). "Case series: Odontohypophosphatasia or missed diagnosis of childhood/adult-onset hypophosphatasia? – Call for a long-term follow-up of premature loss of primary teeth." Bone Reports 5: 228-232. Munday, L. (2009). "Post radioiodine monitoring: Do patients feel telephone consultations are an acceptable part of a nurse-led clinic?" Endocrine Abstracts 19: P343. Munshi, L. B., et al. (2017). "BRCA-1 associated with pheochromocytoma and parathyroid adenoma." Endocrine Reviews 38(3). Nadeem, A., et al. (2010). "Interferon-alpha Induced and Ribavirin induced thyroid dysfunction in patients with chronic hepatitis C." Hepatitis Monthly 10(2): 132-140. Naji, P., et al. (2013). "Graves' disease causing pancytopenia and autoimmune hemolytic anemia at different time intervals: A case report and a review of the literature." Case Reports in Medicine 2013. Nakatake, N., et al. (2011). "Prediction of post-treatment hypothyroidism using changes in thyroid volume after radioactive iodine therapy in adolescent patients with Graves' disease." International Journal of Pediatric Endocrinology 2011(1). Negro, R., et al. (2016). "A 2015 Italian Survey of Clinical Practice Patterns in the Management of Graves' Disease: Comparison with European and North American Surveys." European Thyroid Journal 5(2): 112-119. Niaz, W., et al. (2017). "A case of severe acquired hypothyroidism occurring 9 weeks after radioactive idodine therapy for graves' disease." Endocrine Reviews 38(3). Niwattisaiwong, S. (2013). "Subacute thyroiditis misdiagnosed as graves' disease resulting in severe hypothyroidism." Endocrine Reviews 34(3). Noh, J. Y., et al. (2015). "Prevention of hyperthyroidism exacerbation during radioactive iodine therapy in a patient with graves' disease and a huge goiter." Thyroid 25: A67-A68. Norman, C., et al. (2011). "Predictors of resistance to radioiodine ablation for graves disease." Endocrine Reviews 32(3). Palacios, S. S., et al. (2012). "Management of subclinical hyperthyroidism." International Journal of Endocrinology and Metabolism 10(2): 490-496. Palitzsch, K. D. (2017). "Thyroid disease in old age." Internistische Praxis 58(1): 51-64. Paragas, S. M. O. and P. D. Maningat (2017). "Subacute thyroiditis presenting as rapidly enlarging thyroid nodule post dengue infection: A case report." Endocrine Reviews 38(3). Pernicova, I., et al. (2009). "Hyperthyroidism: Retrospective audit on patients' follow-up post radioiodine therapy." Endocrine Abstracts 19: P396. Pitoia, F., et al. (2011). "How to increase radioiodine uptake in multinodular goiters by using metil mercapto imidazole." Thyroid 21: A101. Pitoia, F., et al. (2011). "Increasing radioiodine uptake for the treatment of non autoimmune multinodular goiter." European Thyroid Journal: 155-156. Poiana, C., et al. (2011). "Thyroid nodules in patients with malignancies." European Thyroid Journal: 182. Poste, J., et al. (2015). "Clinical outcomes after calculated activity of radioiodine for the treatment of benign hyperthyroid disease at westchester medical center. A retrospective analysis." Endocrine Reviews 36. Prakash, O., et al. (2010). "Detection and treatment of hyperthyroidism in sea costal areas and chemically polluted areas in Gujarat, (western part) India." Indian Journal of Nuclear Medicine 25(3): 99. Priatna, et al. (2017). "Effect of radioiodine (I-131) to tsh, T3 and FT4 hormone levels in hyperthyroidism high uptake patients." Trends in Medical Research 12(1): 14-19. Proenca, M., et al. (2013). "Prognostic value of subclinical hyperthyroidism in an internal medicine ward." European Journal of Internal Medicine 24: e102. Quidute, A. R., et al. (2010). "Regression of pulmonary arterial hypertension after treatment of hyperthyroidism." Endocrine Abstracts 20: P131. Rehman, R. A. and E. Nyenwe (2012). "Papillary thyroid carcinoma in a toxic adenoma." Journal of Investigative Medicine 60(1): 350-351. Romão, R., et al. (2007). "A 3-year follow-up of recombinant human thyrotropin (rhTSH) prior to 30 mCi of radioiodine in the outpatient treatment of multinodular goiter (MNG)." Thyroid 17: S132. Saeed, K. R., et al. (2012). "Association of hyperthyroidism and duodenal ulcer." Surgical Endoscopy and Other Interventional Techniques 26: S430. Saeedinia, S., et al. (2013). "Evaluation of anti-thyroid drugs, radioactive iodine and surgery in patients with hyperthyroidism." Iranian Journal of Endocrinology and Metabolism 14(6): 1-8. Şaki, H., et al. (2014). "Effectiveness of radioiodine treatment for toxic nodular goiter." European Journal of Nuclear Medicine and Molecular Imaging 41: S542. Salman, S., et al. (2010). "Evaluation of the association between bone turnover markers and OPG/sRANK-L levels in relation with the changes of thyroid function in women with thyroid cancer." Endocrine Abstracts 20: P238. Salvaneschi, J. P. and J. R. A. R. García (2009). "Endemic goiter in the Argentine Republic: Antecedents, extension, and magnitude of the endemic disease before and after the use of iodized salt. Second part." Revista Argentina de Endocrinologia y Metabolismo 46(2): 35-57. Sambo, M. E., et al. (2015). "Radiofrequency ablation (RFA) in the clinical, morphological and functional control of large, solids, symptomatic and benign thyroid nodules: Justification and preliminary safety outcomes of a multicenter study." Endocrine Reviews 36. Sanchez, L. M. P., et al. (2013). "Clinical presentation and response to therapy of graves' disease in a multi-ethnic endocrine clinic." Endocrine Reviews 34(3). Saumoy, M., et al. (2012). "Hyperbilirubinemia as a presenting symptom of thyrotoxicosis in a patient with sickle cell disease." American Journal of Gastroenterology 107: S422. Shehata, N., et al. (2015). "Rare malignant struma ovarii - non-papillary thyroid carcinoma of the ovary." BJOG: An International Journal of Obstetrics and Gynaecology 122: 151-152. Singh, I. and S. Bhat (2015). "Intraductal papillary mucinous neoplasm as new manifestation of mccune albright syndrome." Endocrine Reviews 36. Subramanian, M., et al. (2016). "The effect of prior antithyroid drug use on delaying remission in high uptake Graves' disease following radioiodine ablation." Endocrine Connections 5(1): 34-40. Sundaresh, V., et al. (2012). "Comparative effectiveness of treatment choices for graves' hyperthyroidism: Experience of a tertiary referral center." Thyroid 22: A87. Sundaresh, V., et al. (2013). "Comparative effectiveness of treatment choices for graves' disease in the elderly population: Experience of a tertiary referral center." Endocrine Reviews 34(3). Sundaresh, V., et al. (2017). "Comparative Effectiveness of Treatment Choices for Graves" Hyperthyroidism: A Historical Cohort Study." Thyroid 27(4): 497-505. Taboada, G. F., et al. (2005). "Struma ovarii and concomitant thyroid disease: Report of two cases." Endocrinologist 15(2): 79-81. Taghavi, S. M. (2010). "Outcome of fix and uncalculated dose of radioiodine in the treatment of hyper functioning thyroid nodules." Iranian Journal of Nuclear Medicine 18: 97. Tarasova, V. D., et al. (2013). "A novel mutation of thyroid receptor beta subunit causing resistance to thyroid hormone." Thyroid 23: A66-A67. Thirion, M., et al. (2006). "Thyrotoxicosis." Reanimation 15(6): 497-505. Thirumalai, A. and S. Trikudanathan (2015). "Radioiodine ablation for amiodarone- induced thyrotoxicosis allows re-introduction of the drug." Thyroid 25: A217. Triay, J. and P. Singhal (2010). "Improving the accuracy of clinical diagnosis in hyperthyroid disorders using ultrasound assessment." Endocrine Abstracts 22: P792. Trifanescu, R. A., et al. (2015). "Papillary thyroid carcinoma in insulinoma patients: Simple coincidence, men 1 syndrome or effect of hyperinsulinemia?" Thyroid 25: A292. Truran, P. and S. Aspinall (2014). "Thyrotoxicosis and thyroiditis." Surgery (United Kingdom) 32(10): 537-542. Tufton, N., et al. (2009). "Is long-term follow-up after radio-iodine therapy safe in the current UK health-care climate?" Endocrine Abstracts 19: P394. Tun, N. N., et al. (2016). "Predicting risk of recurrent thyrotoxicosis following thionamide withdrawal in graves disease." Endocrine Reviews 37(2). Vallabhajosula, S., et al. (2010). "Hyperthyroidism is associated with reversible pulmonary hypertension." Journal of Investigative Medicine 58(2): 425. Van Wilder, N., et al. (2017). "Pseudomalabsorption of levothyroxine: A challenge for the endocrinologist in the treatment of hypothyroidism." European Thyroid Journal 6(1): 52- 56. Vija Racaru, L., et al. (2017). "Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders: Real life experience and predictive factors of functional response." Nuclear Medicine Communications 38(9): 756-763. White, R. D. (2004). "Hyperthyroidism: Current standards of care." Consultant 44(8): 1085-1090. Wilhoit, B. and A. DeCastro (2014). "18-Year-old basketball player with profound muscle weakness." Clinical Journal of Sport Medicine 24(2): e2-e3. Wilson, C. (2013). "Thyroid function: Cause of increased mortality differs for Graves disease and toxic nodular goiter." Nature Reviews Endocrinology 9(3): 128. Yaish, I., et al. (2014). "The effect of radioactive iodine 131I treatment on ovarian reserve：Preliminary data from a prospective study." Endocrine Reviews 35. Yilmaz, B., et al. (2010). "Changes in the spectrum of thyroid diseases in geriatric population 10 years after mandatory iodination in Ankara." European Geriatric Medicine 1: S111. Yu, J. and H. S. Han (2010). "Outcome of Graves disease treated with antithyroid drugs in children and adolescents." Hormone Research in Paediatrics 74: 254. Zaletel, K., et al. (2011). "The correlation between Tc-99m and I-123 uptake in patients with thyroid autonomy." European Journal of Nuclear Medicine and Molecular Imaging 38: S154. Zaletel, K., et al. (2011). "The comparison of TC-99m and I-123 uptake in patients with thyroid autonomous tissue." European Thyroid Journal: 159-160.